Home / Contributors / Michelle Mello
Michelle Mello

Michelle Mello, J.D., Ph.D.

Dr. Mello conducts empirical research into issues at the intersection of law, ethics, and health policy. She has written on the medical malpractice system, medical errors and patient safety, research ethics, mass tort litigation, the obesity epidemic, pharmaceuticals, and bioethics. Recent projects include a study of legal relationships between academic investigators and industry sponsors of clinical trials, and an analysis of patient safety regulation.

Positions

  • Associate Professor, Health Policy and Management, Harvard School of Public Health
  • Associate Director, Program in Law and Public Health, Harvard School of Public Health

 

Education

  • J.D., 2000, Yale Law School
  • Ph.D., 1999, University of North Carolina at Chapel Hill, Health Policy and Administration

 

Relevant Publications

  • Mello, M. M., & Brennan, T. A. (2005). Legal concerns and the influenza vaccine shortage. Journal of the American Medical Association, 294, 1817-1820.
  • Studdert, D. M., Mello, M. M., Sage, W. M., DesRoches, C. M., Peugh, J., Zapert, K., & Brennan, T. A. (2005). Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. Journal of the American Medical Association, 293, 2609-2617.
  • Mello, M. M., Rosenthal, M., Neumann, P. J. (2003). Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers. Journal of the American Medical Association, 289, 477-81.
  • Studdert, D. M., Mello, M. M., Brennan, T. A. (2003). Medical monitoring for pharmaceutical injuries: Tort law for the public's health? Journal of the American Medical Association, 289, 889-94.
  • Mello, M. M., Clarridge, B. R., & Studdert, D. M. (2005). Academic medical centers' standards for clinical-trial agreements with industry. New England Journal of Medicine, 352, 2202-2210.

 

Contributed Content